Contrast-enhanced computed tomography to show perivesical extension in bladder carcinoma

Fifty-two patients (53 lesions) with muscle invasive carcinoma (T2/T3) of the urinary bladder were examined with computed tomography (CT) before planned total cystectomy. The object of CT was to demonstrate perivesical growth. All patients were examined before and after intravenous injection of contrast medium. The stages obtained from the precontrast and postcontrast scans were compared with the histopathologic stage from the cystectomy specimen. CT staged correctly 35 of the 53 lesions in the precontrast series and 46 of the 53 lesions in the postcontrast series. The improved accuracy from contrast enhancement resulted primarily from fewer cases being overstaged. The use of intravenous contrast medium improved accuracy of CT in evaluation of perivesical tumor growth.     

Staging of bladder carcinoma: MRI-CT-surgical correlation

Eleven patients with transitional cell carcinoma of the bladder were examined with spin-echo MRI using a superconductive magnet operating at a field strength of 0.35 T. MRI results were compared with the CT findings in 10 of the patients. All subjects later underwent radical cystectomy including pelvic lymph-node dissection. MRI accuracy for staging was 64% using the TNM classification and 73% by the Jewett-Strong-Marshall system while CT accuracy was 40%. MRI provided improved demonstration of tumor invasion of perivesical fat planes, prostate, and seminal vesicles and greater anatomic detail was afforded by direct sagittal and coronal views.     

Clinical and radiologic staging of locally advanced and inoperable bladder carcinoma

Twenty-seven patients with locally advanced and inoperable bladder carcinoma (LABCa) were referred for chemotherapy. All were staged by cytoscopy, examination under anesthesia, and computed tomography (CT), and 18 also had bipedal lymphangiography (LAG). In 16 patients (56%), there was agreement between the clinical and the CT staging of the primary bladder tumor. In four of these 16 patients, CT detected lymphadenopathy in three and demonstrated pelvic bone invasion in one. Of the remaining 11 patients, CT underestimated the local extent of the bladder tumor in nine and overestimated in two. Lymphangiography was abnormal in nine patients (50%), in four of whom the abnormality was not seen on CT scan. Among the ten patients with normal LAG, six had abnormal pelvic nodes detected by CT. The LAG affected the overall staging of the tumor in five patients (16.6%). The total incidence of nodal metastasis as seen on CT, LAG, or both was 72%. Although CT and LAG may not add significantly to the clinical staging of the primary tumor in LABCa, they will affect the overall staging of the tumor by detecting lymphadenopathy. Accurate staging of these patients is important because, with aggressive chemotherapy, some of these patients might become candidates for more radical treatment such as surgery or radiotherapy.     

Computed tomography of the urinary bladder shortly after radiation therapy for rectal carcinoma

Eighteen patients with rectal carcinoma were examined with computed tomography (CT), before and shortly after preoperative irradiation. Changes in the bladder that could be mistaken for tumor growth did not occur at CT. However, considerable individual variations were seen. Radiation therapy did not result in increased contrast enhancement of the bladder wall after irradiation. The bladder wall thickness increased somewhat during and after treatment and the bladder volume was reduced. Localized thickening with little contrast enhancement was seen in the anterior bladder wall in 3 patients. One case of irradiation cystitis was noted. Edema was seen in the perivesical fat, but could in no case be mistaken for tumor growth.     

Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.

Lymph node involvement is a major prognostic factor in bladder cancer, but the accuracy of conventional imaging modalities for the prediction of regional and distant metastatic diseases is limited. This study was performed to compare the diagnostic accuracies of contrast-enhanced CT and PET with (11)C-choline for the staging of urothelial bladder cancer. METHODS: Twenty-seven patients (median age, 69.1 y) who had urothelial bladder cancer and who were referred for radical cystectomy and pelvic lymph node dissection (PLND) on the basis of a histologic evaluation after transurethral resection of bladder cancer (TURB) were studied. PET scanning, using 2 multiring whole-body tomographs, was performed 5 min after intravenous injection of approximately 370-500 MBq of (11)C-choline. In addition, conventional bone scintigraphy and contrast-enhanced CT were performed. After imaging, cystectomy and PLND were performed in all patients. Pathologic (11)C-choline uptake that could not be explained by intestinal activity was noted as a positive result. Node positivity was determined by size on CT: nodes measuring more than 1 cm in the long axis were described as being positive for tumor. Histopathologic findings were used as a reference. RESULTS: The presence of residual bladder cancer (pTa-pT4) was correctly detected in 21 of 25 histologically tumor-positive patients (84%) by CT and in 24 of 25 patients (96%) by (11)C-choline PET. Lymph node involvement was correctly detected in 4 of 8 patients (50%) by CT and in 5 of 8 patients (62%) by (11)C-choline PET. The median size of the 3 nodes with false-negative PET results was 9 mm (range, 6-21 mm), and the median size of the metastatic lesions within the lymph nodes was 3 mm (range, 1-15 mm). CT resulted in 6 (22%) false-positive lymph nodes, whereas none was demonstrated by (11)C-choline PET; these data indicated a significantly higher accuracy of PET than of CT (P < 0.01). Both modalities missed a small peritoneal metastasis verified by histologic evaluation. No positive results were obtained from bone scintigraphy. CONCLUSION: These preliminary data suggest that (11)C-choline PET is comparable to CT for detecting residual bladder cancer after TURB but appears to be superior to CT for the evaluation of potential additional lymph node metastases. (11)C-choline PET should be further evaluated for staging in patients who have bladder cancer and who are scheduled for radical cystectomy.     

CT evaluation of bladder and prostate neoplasms

The role of computed tomography in the preoperative staging of bladder and prostate tumors is discussed and illustrated. The accuracy of judging perivesical tumor extent, various techniques of CT examination, and the clinical significance of evaluating local bladder extension are discussed. The CT evaluation of local periprostatic extension of tumor is examined in relationship to the type of planned therapy. A dynamic technique for lymphadenopathy evaluation is detailed. The accuracy of demonstrating lymphadenopathy by CT and its therapeutic impact on the surgical treatment of bladder and prostate malignancies are discussed.     

MR staging of bladder carcinoma: correlation with pathologic findings

Forty patients with bladder carcinoma were examined preoperatively by means of magnetic resonance (MR) imaging. In all patients, total cystectomy with enterocystoplasty and pelvic node dissection was performed. The surgical and pathologic findings were correlated with the MR findings. Extension through the deep muscle of the bladder wall was present in 20 of the 40 patients and was diagnosed with a sensitivity of 95% and a specificity of 95%. Extension to perivesical fat was present in 18 of 40 patients and was diagnosed with a sensitivity of 66% and a specificity of 100%. Invasion of the adjacent organs was present in nine of 40 patients and was diagnosed with a sensitivity of 44% and a specificity of 96%. On the basis of the MR findings, the tumor was correctly staged, according to the TNM classification, in 24 of 40 (60%) patients, tumor extension was overestimated in three of 40 (7.5%) patients, and tumor extension was underestimated in 13 of 40 (32.5%) patients. MR imaging has been shown to be accurate in identification of macroscopic lymph node involvement and deep muscle involvement. It appears to be at least as useful as computed tomography (CT) in the evaluation of perivesical fat involvement and to be superior to CT in the detection of invasion of adjacent organs. One limitation of MR imaging is in the evaluation of tumor extension into the periurethral glands.     

Contribution of MRI in the staging of cancer of the bladder. Apropos of 40 cases

56 patients with bladder carcinoma were examined by magnetic resonance in the pre-operative staging. In 40 patients where total cystectomy with enterocystoplasty and pelvic node dissection were performed, a good correlation with surgical and pathologic findings was obtained. MR examination using T1 (TR 400 ms, TE 28 ms) and T2 (TR 1,200-1,600 ms, TE 40 80 120 ms) weighted images in different planes where performed after biopsy of the bladder tumor through endoscopy and within 1 or 2 weeks before surgery. Neoplasms were characterized by site, size and growth pattern. Extension through the deep muscle of the bladder wall was correctly identified in 95% with a sensitivity of 95% and a specificity of 95%. Extension through perivesical fat was assessed accurately in 85% with a sensitivity of 66% and a specificity of 100%. Accuracy in evaluating invasion of adjacent organs was 85%, sensitivity 44%, specificity 96%. Lymphadenopathy has been accurately assessed in 97.5% with a sensitivity of 83% and a specificity of 100%. MR correctly staged the tumor according to TNM classification in 24/40 (60%) patients, overestimated the extension in 3/40 (7.5%) and underestimated the extension in 13/40 (32.5%).     

Features of irradiated urinary bladder tumors and their correlation with malignancy observed on computed tomography

CT features of 42 masses in the bladder wall were characterized and subjected to analysis to find indicators of malignancy. A CT technique with thin slices and intravenous contrast medium was used. Multiple regression and multivariate analysis showed good ability of contrast-enhanced CT to discriminate between benign and malignant masses in the bladder wall. Protrusion of a mass into the perivesical fat had some importance in discriminating between malignant tumors with and without perivesical growth although the detection of perivesical growth was less certain.     

Prospective evaluation of MRI,C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer

Purpose

To prospectively evaluate the diagnostic performance of magnetic resonance imaging (MRI), ¹¹C-acetate positron emission tomography/computed tomography (PET/CT) and contrast-enhanced CT for bladder cancer staging, using whole-mount pathologic review of radical cystectomy and pelvic lymph node specimens as the reference standard.

Materials and methods

The institutional review board approved this prospective study, which was compliant with the Health Insurance Portability and Accountability Act. Written informed consent was obtained from 16 patients with histologically confirmed bladder cancer who underwent MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT before radical cystectomy and pelvic lymph node dissection. Before imaging 4/16 patients had received intravesical Bacillus Calmette-Guérin treatment, 6 had received systemic chemotherapy, 3 had received both and 3 had received neither. Measures of diagnostic performance including accuracy, sensitivity and specificity were estimated separately for each imaging modality.

Results

MRI correctly staged 56% of patients (9/16), overstaged 38% (6/16) and understaged 6% (1/16). CT correctly staged 50% of patients (8/16), overstaged 44% (7/16) and understaged 6% (1/16). In 9 patients, ¹¹C-acetate PET/CT showed uptake within the bladder wall; the uptake was true-positive in 7 patients and false-positive in 2 patients. Of the remaining 7 patients, 5 had true-negative and 2 had false-negative PET/CT results for cancer in the bladder wall. For all modalities, staging accuracy was reduced in patients with a history of prior intravesical and/or systemic chemotherapy.

Conclusion

In staging bladder cancer, MRI, ¹¹C-acetate PET/CT and CT displayed similar levels of accuracy. For all modalities, a history of intravesical and/or systemic chemotherapy affected staging accuracy.     

Urachal carcinoma: CT findings

The computed tomographic (CT) appearance of urachal carcinoma in ten patients was studied and compared with the pathologic findings. Magnetic resonance images were available in one case. All tumors were mucinous adenocarcinomas; four were solid, three were cystic, and three were mixed. The tumor had a characteristic location along the expected midline course of the urachus directly behind the anterior abdominal wall. The main tumor mass was supravesical in eight patients. Seven tumors contained calcification. CT correctly depicted bladder wall involvement and supravesical extent of tumor in all cases. CT provided incorrect information about invasion of the perivesical fat in three patients and about bladder mucosal invasion in two patients.     

CT features of bladder small cell carcinoma

Computed tomography (CT) features of six patients with pathologically proven bladder small cell carcinoma (SCC) were analyzed retrospectively. CT revealed these tumors as large, enhancing, broad-based polypoid intramural masses with or without cystic portions, extending to the perivesical area. Tumor calcification was found in one patient, and lymphadenopathy in four patients. The staging at the time of diagnosis was C in three patients, and D1 in another three patients. Follow-up CT showed brain metastasis in one patient, and liver metastasis in two patients.     

MR imaging of urinary bladder neoplasms

The diagnostic potential of magnetic resonance (MR) imaging at 1.5 T for assessment and staging of urinary bladder tumors was investigated in 10 patients with malignant urinary bladder tumors. All patients underwent complete pathologic staging. The appearance of the urinary bladder tumors and the ability to stage them by means of MR imaging was evaluated morphologically and compared with results obtained with pathologic examination. Magnetic resonance imaging permitted tumor localization in all patients. In nine patients the tumor stage was accurately determined by MR imaging. The smallest tumor detected by MR imaging was 1.5 cm. Both transverse and sagittal imaging planes were found to be essential for accurate assessment of tumor extension. Signal intensity data obtained from both dual and multi spin echo sequences showed that tumor display and depth of infiltration was best seen with a repetition time (TR) of 2,000 ms and an echo time (TE) of 90 ms. Accurate evaluation of perivesical tumor infiltration required a sequence with a TR 800 ms and a TE 30 ms. Data presented here further support the role of MR in staging urinary bladder neoplasms.     

CT in determining the depth of infiltration of bladder tumors

The findings from 141 CT investigations of bladder tumors are compared with histopathological staging (103 cases) and clinical staging (36 cases). Twenty-five tumors could not be seen on CT and 2 tumors could not be staged because of artifacts caused by hip prosthesis. When the tumor was visible at CT and there was histological confirmation of the depth of the infiltration, we were able to differentiate extravesical tumor stages T3b and T4 from each other and from all the other stages in 49 of 59 cases (83%). However, CT failed to differentiate superficial from intramural tumor stages. The greatest value of CT in staging bladder tumors is in cases of deeply infiltrating tumors; examination should be made before biopsy or any therapeutic procedures are begun.     

CT in determining the depth of infiltration of bladder tumors

The findings from 141 CT investigations of bladder tumors are compared with histopathological staging (103 cases) and clinical staging (36 cases). Twenty-five tumors could not be seen on CT and 2 tumors could not be staged because of artifacts caused by hip prosthesis. When the tumor was visible at CT and there was histological confirmation of the depth of the infiltration, we were able to differentiate extravesical tumor stages T3b and T4 from each other and from all the other stages in 49 of 59 cases (83%). However, CT failed to differentiate superficial from intramural tumor stages. The greatest value of CT in staging bladder tumors is in cases of deeply infiltrating tumors; examination should be made before biopsy or any therapeutic procedures are begun.     

Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique

Purpose

Positron emission tomography/computed tomography (PET/CT) with ¹⁸F-fluorodeoxyglucose (FDG) has been used with limited success in the past in primary diagnosis and locoregional staging of urinary bladder cancer, mainly because of the pharmacokinetics of renal excretion of ¹⁸F-FDG. In the present prospective study, we have evaluated the potential application of diuretic ¹⁸F-FDG PET/CT in improving detection and locoregional staging of urinary bladder tumours.

Methods

Twenty-five patients suspected of having primary carcinoma of the urinary bladder were evaluated prospectively for diagnosis and staging. All of these 25 patients underwent conventional contrast-enhanced computed tomography (CECT) of the abdomen/pelvis and whole-body diuretic ¹⁸F-FDG PET/CT. In addition, pelvic PET/CT images were obtained using the special technique of forced diuresis using intravenous furosemide (20–40 mg). Of the 25 patients, 10 underwent radical cystectomy and 15 underwent transurethral resection of the bladder tumour (TURBT). Results of CECT and diuretic ¹⁸F-FDG PET/CT were compared considering histopathology as a reference standard.

Results

Of the 25 patients, CECT detected a primary tumour in 23 (sensitivity 92 %), while ¹⁸F-FDG PET/CT was positive in 24 patients (sensitivity 96 %). Mean size and maximum standardized uptake value of the bladder tumours were 3.33 cm (range 1.6–6.2) and 5.3 (range 1.3–11.7), respectively. Of the 25 patients, only 10 patients underwent radical cystectomy based on disease status on TURBT. Among those ten patients, nine had locoregional metastases. Among the nine patients who had positive lymph nodes for metastasis on histopathology, CECT and PET/CT scan had a sensitivity of 44 and 78 %, respectively. ¹⁸F-FDG PET/CT was found to be superior to CECT in the detection of the primary tumour and locoregional staging (p?<?0.05).

Conclusion

Diuretic ¹⁸F-FDG PET/CT is highly sensitive and specific and plays an important role in improving detection of the primary tumour and locoregional staging of urinary bladder tumours. Diuretic ¹⁸F-FDG PET/CT demonstrated a higher diagnostic value when compared with CECT in these patients.     

膀胱癌多层螺旋CT分期与手术病理对照

目的 分析膀胱癌多层螺旋CT表现及CT分期.资料与方法 总结分析44例经手术、病理证实的膀胱癌的多层螺旋CT表现.结果 44例均为移行上皮细胞癌,膀胱癌的多层螺旋CT表现为膀胱壁弥漫性均匀增厚1例,单发结节状肿块22例,多发菜花状肿块21例,病灶呈轻至中度强化,可向腔内或膀胱壁外生长,累及膀胱周围脂肪层及相邻器官和淋巴结转移;33例为T1和T2期的患者24例基底强化线完整,11例为T3和T4期的患者中只有1例基底强化线完整.与病理分期对照,CT分期的准确率达68.2%.结论 多层螺旋CT薄层增强扫描能够显示膀胱癌的特征,可提高膀胱癌的CT分期准确率.     

Urinary bladder MR imaging. Part II. Neoplasm

The potential of magnetic resonance (MR) imaging for the evaluation and staging of bladder tumors was analyzed in 15 patients (11 cases of transitional cell carcinoma, two adenocarcinomas, one leiomyosarcoma, and one leiomyoma). Neoplasms were characterized by size, site, and growth pattern, and the accuracy of the staging was compared with the results of computed tomography and pathologic study. Malignancies were accurately detected and staged by MR imaging in 12 of 14 patients (85%). Tumor site and degree of bladder distention did not adversely affect detection; tumors greater than 1.5 cm were detected easily. In situ carcinoma (stage Tis) was not detected on MR images. Imaging in both sagittal and transverse planes was needed for optimal bladder evaluation. Bladder carcinoma was best displayed with a short echo delay time (TE) of 28 msec and repetition (TR) times of 1.0-2.0 sec: TR = 1.0 gave 34% contrast and TR = 2.0 gave 36% contrast between tumor and surrounding urine. Bladder-wall invasion by tumor was best evaluated with long TR (2.0 sec) and long TE (56 msec) (82% contrast). For assessing tumor extension into perivesical fat, short TR (0.5 sec) and TE (28 msec) were optimal (58% contrast). MR imaging offers an increased sensitivity for tumor detection and promises to greatly improve the staging of bladder neoplasms.     

Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging

PURPOSE: To evaluate the enhancement pattern of bladder cancer and the accuracy of multi-detector row helical computed tomography (CT) in the detection and staging of bladder cancer. MATERIALS AND METHODS: In 20 patients, the attenuation value of bladder cancer was measured on dynamic contrast material-enhanced multiphasic CT images obtained with scanning delays of 40, 60, 80, and 100 seconds. In 67 patients, CT data were obtained with a 60-second scanning delay that covered the bladder (section thickness, 2.5 mm; beam pitch, 1.5) and a 180-second scanning delay that covered the abdomen (section thickness, 5 mm; beam pitch, 1.5). We prospectively evaluated CT images and compared findings at CT with findings at histologic examination. We evaluated cancer detection rate, positive predictive value of cancer detection, and sensitivity and specificity in the diagnosis of perivesical invasion. RESULTS: The attenuation value of bladder cancers was significantly higher on 60- (105 HU +/- 16) and 80-second (97 HU +/- 15) delayed CT images than on the other images (P <.05). The cancer detection rate and positive predictive value for cancer detection were 97% and 95%, respectively, in 67 patients and increased to 100% and 100%, respectively, in 44 patients with a time interval of 7 or more days between transurethral resection of the bladder (TURB) and CT examination. Sensitivity and specificity in the diagnosis of perivesical invasion were 89% and 95%, respectively, in 67 patients and increased to 92% and 98%, respectively, in 44 patients with a time interval of 7 or more days between TURB and CT examination. CONCLUSION: Bladder cancer tends to show peak enhancement with the 60-second scanning delay. Multi-detector row helical CT is useful in the detection and staging of bladder cancer.     

Orthotopic neobladder reconstruction: findings on excretory urography and CT

OBJECTIVE: The excretory urographic and CT appearance of orthotopic ileal neobladder reconstruction after cystectomy and its complications are described. MATERIALS AND METHODS: We retrospectively reviewed the excretory urograms and CT scans of 32 patients (29 men and three women, 35-76 years old) with transitional cell carcinoma of the bladder who underwent orthotopic neobladder reconstruction with anastomosis to the native urethra after cystectomy. The radiologic review consisted of 25 excretory urograms in 20 patients and 37 CT scans in 21 patients. RESULTS: On excretory urography, the afferent segment of the neobladder was identified as a contrast-filled structure in all 20 patients, and was located in the right lower quadrant in 18 (90%). On CT, the afferent segment and the neobladder were identified in all 21 patients. Delayed imaging performed after initial scanning in 12 (57%) of 21 patients was helpful for revealing detailed anatomy such as the ureteral-afferent limb anastomoses. Complications occurred in two patients and were caused by a lymphocele in one and a urine leak from the neobladder in the other. In six other patients we found evidence of recurrent or metastatic tumor or both: two had local pelvic recurrence and pelvic nodal metastases, two other patients had metastatic nodal disease, one patient had a malignant distal ureteral stricture, and the sixth patient had distant osseous metastases. CONCLUSION: Orthotopic neobladder reconstruction after cystectomy has a characteristic appearance on both excretory urography and CT. Knowledge of this appearance and the altered anatomy is useful to recognize complications and tumor recurrence. Delayed images during excretory urography and CT are useful to define the ureteral-afferent limb anastomosis with the neobladder and also to differentiate between postoperative collections.